We have observed
9 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 24, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS BASED ON SHORT CHAIN FATTY ACIDS
DEFIBROTIDE FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD).
Solid oral composition containing dyes for use in endoscopic diagnosis
PHARMACEUTICAL COMPOSITION COMPRISING A DRUG CONTAINING AT LEAST ONE TOXICOPHORE FUNCTION AND N-ACETYL-L-CYSTEINE
New process for the synthesis of aminaphtone
Iron bisglycinate chelate for use in treating anaemia
BAG3 as biochemical serum and tissue marker
USE OF MEXIPROSTIL IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND/OR OF IRRITABLE BOWEL SYNDROME